2004-10-07

Adis International Recognized for its Strong Dedication to Employee Development


Chester, England (ots/PRNewswire) -

- Accepts Prestigious 2004 'Investors in People' Award

Wolters Kluwer Health, Pharma Solutions business unit todayannounced that Adis International was named a 2004 "Investor inPeople" by the Investors in People UK Recognition Panel. TheLondon-based organization assesses corporate business practicesagainst a national standard and recognizes only those companies thatmeet or exceed those requirements.

The Adis offices in Chester, Oxford and London were recognized fora superior commitment to supporting the development of its people. Afull-scale assessment, which included interviews with 31 employees,determined that the company had moved forward, improved methods ofcommunication and forged a "very positive attitude and atmospherefrom staff."

"The development of our people is of paramount importance to us,"said Peter George, EVP of Europe and Asia Pacific. "It is alsocompletely in line with our business objective to always strive forimprovement. To be a guiding force tomorrow, we must invest in ourpeople today."

"Investors in People" is a national standard that sets out a levelof good practice for training and development of people to achievebusiness goals. The standard provides a national framework forimproving business performance and competitiveness, through a plannedapproach to setting and communicating business objectives anddeveloping people to meet these objectives.

The Investors in People (UK) program was established in 1993 toprovide national ownership of the Investors in People Standard and isresponsible for its promotion and branding, quality assurance anddevelopment. Since 1991, tens of thousands of UK employers havebecome involved with the standard.

As part of Wolters Kluwer Health, Pharma Solutions business unit,Adis International is one of the preeminent information providers tothe pharmaceutical and biotechnology markets. Adis journals are amongthe most-cited publications in their respective fields, and provide aunique blend of original articles, authoritative reviews, profiles,and drug evaluations.

For more information about the Investors in People program, visithttp://www.iipuk.co.uk. For more about Adis and Wolters KluwerHealth, Pharma Solutions, visit http://www.wkhealth.com orhttp://www.adis.com.

About Wolters Kluwer Health

The Wolters Kluwer Health Pharma Solutions division providesinformation and communications support for the pharmaceuticalindustry, from drug discovery and research to launch and marketingunder the industry's leading medical information brands, AdisInternational, IFI Claims and Lippincott Williams & Wilkins.

Wolters Kluwer Health is a unit of WoltersKluwer nv, a leadingmultinational publisher and information services company with annualrevenues (2003) of euro 3.4 billion and employing approximately18,750 people worldwide. Wolters Kluwer is headquartered inAmsterdam, the Netherlands. Its depositary receipts of shares arequoted on the Euronext Amsterdam (WKL) and are included in the AEXand Euronext 100 indices.

For more information, visit http://www.adis.com andhttp://www.wkhealth.com

Contact: Tom Kivett Kivett & Company Communications +1-212-727-2935 tkivett@kivettandco.com Web site: http://www.wkhealth.com http://www.adis.com http://www.iipuk.co.uk

ots Originaltext: Wolters Kluwer Health, Pharma SolutionsIm Internet recherchierbar: http://www.presseportal.de

Contact:Tom Kivett of Kivett & Company Communications, +1-212-727-2935, tkivett@kivettandco.com, for Wolters Kluwer Health, Pharma Solutions

Wolters Kluwer Health, Pharma Solutions

Zurück zur Übersiche Medizin-Nachrichten

Preisvergleich Medikamente
Medikament oder PZN:   
In Zusammenarbeit mit Medizinfuchs

News

Adis International Recognized for its Strong Dedication to Employee Development

Medizin-News